NCT07877844Completed
Prevalence, Clinical Characteristics and Treatment of Bulgarian Patients With Resistant Hypertension
Prevalence, Clinical Characteristics and Treatment of Bulgarian Patients With Resistant Arterial Hypertension: a Single-center Study.
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
Study objectives: Our study aimed to assess the prevalence, characteristics, and treatment of patients with resistant hypertension (HTN) in Bulgarian hypertensive population. Methods: We screened 4340 consecutive cardiovascular patients hospitalized in our clinic and identified 3762 with HTN. Of them, 128 fulfilled the current (2018) European Society of Cardiology and (2023) European Society of Hypertension criteria for resistant HTN and were included in our study. We matched these patients to 128 hospitalized patients with controlled HTN.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 256 (actual)
- First submitted
- 10 Oct 2026
- Start date
- 1 Jul 2018
- Primary completion date
- 27 Mar 2024
- Lead sponsor
- Medical University of Sofia
- Diseases
- High blood pressure
- NCT number
- NCT07877844
What you commit to
- Study type: Observational
- Participants enrolled: 256
- From 1 Jul 2018 to the primary completion date, 27 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- (1) patients with HTN at target BP values achieved using ≤3 antihypertensive drugs; (2) patients with uncontrolled HTN using
Other illness
- ≥3 drugs, but not at optimal doses or not including ACEi/ARB + CCB + thiazide/thiazide-like diuretic or a treatment period of \<1 month; (3) an established diagnosis of "secondary HTN"; (4) suspected/confirmed pseudo-resistant HTN; and (5) patient clinical condition and/or comorbid factors/diseases making the planned instrumental investigations unfeasible.
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Deparment of Internal Diseases "Prof. St. Kirkovich", UMHAT "Alexandrovska", Medical University of Sofia Coordinator of this site? Confirm its status | Sofia | Bulgaria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.